Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2024. Start Trial.
Date Value
November 18, 2026 2.977B
November 17, 2026 2.941B
November 16, 2026 2.963B
November 13, 2026 3.069B
November 12, 2026 3.113B
November 11, 2026 3.237B
November 10, 2026 3.143B
November 09, 2026 3.293B
November 06, 2026 3.205B
November 05, 2026 3.133B
November 04, 2026 3.218B
November 03, 2026 3.001B
November 02, 2026 3.007B
October 30, 2026 3.024B
October 29, 2026 3.164B
October 28, 2026 3.079B
October 27, 2026 3.001B
October 26, 2026 2.987B
October 23, 2026 3.041B
October 22, 2026 3.174B
October 21, 2026 3.340B
October 20, 2026 3.724B
October 19, 2026 3.582B
October 16, 2026 3.565B
October 15, 2026 3.524B
Date Value
October 14, 2026 3.551B
October 13, 2026 3.643B
October 12, 2026 3.769B
October 09, 2026 3.741B
October 08, 2026 3.673B
October 07, 2026 3.711B
October 06, 2026 3.595B
October 05, 2026 3.629B
October 02, 2026 3.517B
October 01, 2026 3.575B
September 30, 2026 3.660B
September 29, 2026 3.786B
September 28, 2026 3.881B
September 25, 2026 3.823B
September 24, 2026 3.775B
September 23, 2026 3.762B
September 22, 2026 3.993B
September 21, 2026 3.775B
September 18, 2026 4.210B
September 17, 2026 4.181B
September 16, 2026 3.952B
September 15, 2026 4.292B
September 14, 2026 3.935B
September 11, 2026 3.769B
September 10, 2026 3.976B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Mesoblast Ltd. 1.554B
Immutep Ltd. --
CSL Ltd. --
Ceryvyn Therapeutics Ltd. --
Propanc Biopharma, Inc. 1.880M

Enterprise Value Related Metrics